The "Heart Transplantation Therapeutics Market by Product and Geography - Forecast and Analysis 2020-2024" report has been added to ResearchAndMarkets.com's offering.
Global Heart Transplantation Therapeutics Market: About this market
The heart transplantation therapeutics market analysis considers sales from immunosuppressants and supplementary medications products. Our study also finds the sales of heart transplantation therapeutics in Asia, Europe, North America, and ROW. In 2019, the immunosuppressants segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as mechanism of actions (MoA) of these drugs to treat and prevent organ rejection will play a significant role in the immunosuppressants segment to maintain its market position. Also, our global heart transplantation therapeutics market report looks at factors such as rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency of immunosuppressants for heart transplantation. However, adverse effects of immunosuppressants, demand-supply imbalance for organ transplantation, and long-term complications associated with heart transplantation may hamper the growth of the heart transplantation therapeutics industry over the forecast period.
Global Heart Transplantation Therapeutics Market: Overview
High dependency on immunosuppressants for heart transplantation
Various advances in surgical techniques, especially organ transplants and the prevalence of severe coronary artery disease and dilated cardiomyopathy are leading to an increase in the need for heart transplantation surgeries. However, heart transplantation can lead to several types of heart transplant rejection such as acute cellular rejection, acute antibody rejection, and coronary artery vasculopathy chronic rejection. This is driving the need for heart transplantation therapeutics to prevent transplant rejection. Immunosuppressants are used to prevent transplant rejection caused by immune system. Thus, the high dependency on immunosuppressants for heart transplantation will lead to the expansion of the global heart transplantation therapeutics market at a CAGR of almost 3% during the forecast period.
Advent of techniques for organ transplantation
The number of heart transplantation procedures is substantially high, especially in developed countries, due to the high prevalence of risk factors for heart impairment. Currently, the market is witnessing rapid development in the field of regenerative therapies, such as cell therapy, gene therapy, and tissue engineering, which also involve the development of heart and/or other organs. The introduction of novel approaches for heart regeneration and transplantation is one of the key heart transplantation therapeutics market trends. Organ printing is a modern technology, which is a layer-by-layer additive robotic bio-fabrication of 3D functional living macro tissues and organ constructs using tissue spheroids as building blocks. This development is expected to have a positive impact on the overall market growth.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Immunosuppressants - Market size and forecast 2019-2024
- Supplementary medications - Market size and forecast 2019-2024
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Advent of techniques for organ transplantation
- Increasing strategic alliances
- Growing international collaborations for organ transplantation
PART 12: VENDOR LANDSCAPE
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AbbVie Inc.
- Astellas Pharma Inc.
- Cadila Healthcare Ltd.
- F. Hoffmann-La Roche Ltd.
- Mylan NV
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Veloxis Pharmaceuticals A/S
For more information about this report visit https://www.researchandmarkets.com/r/dgkhoi
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900